To advocate for the urgent formal recognition of Type 5 Diabetes Mellitus as a distinct form of non-autoimmune, lean diabetes linked to early-life malnutrition.
Key Findings:
Type 5 Diabetes is characterized by impaired insulin secretion and preserved insulin sensitivity, with significant implications for treatment.
It is strongly associated with malnutrition-induced epigenetic reprogramming and gut microbiota dysbiosis, which may affect disease progression.
The condition is prevalent in low-income and middle-income countries but remains underdiagnosed and poorly understood, leading to inadequate healthcare responses.
Interpretation:
Recognition of Type 5 Diabetes is critical for advancing health equity and improving clinical outcomes, particularly in underserved populations.
Limitations:
Insufficient acknowledgment by the WHO and inadequate phenotyping of Type 5 Diabetes hinder effective management.
Lack of prospective cohort studies and mechanistic research complicates understanding of its natural history, leading to potential mismanagement.
Misdiagnosis may occur due to overlap with other atypical diabetes variants, resulting in inappropriate treatment and care.
Conclusion:
Establishing standardized classification and region-specific management protocols for Type 5 Diabetes is imperative to address the urgent healthcare needs of affected populations.
"AI could help reduce the burden on ophthalmology services by triaging large numbers of patients with diabetes and allowing specialists to focus on those who most urgently need care."
